MyAverix Finance
NS · Pharmaceuticals
Gland Pharma Ltd (GLAND)
Pharmaceuticals & Biotechnology
Gland Pharma Ltd (GLAND) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $376.63B, P/E ratio is 28.98, net margin is 25.3%, dividend yield is 0.79%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GLAND
Gland Pharma Ltd (GLAND) — FAQ
What is Gland Pharma Ltd's market cap?
Gland Pharma Ltd (GLAND) has a reported market cap of $376.63B (data as of 2026-07-10).
What is GLAND's P/E ratio?
The price-to-earnings (P/E) ratio for Gland Pharma Ltd (GLAND) is 28.98 (data as of 2026-07-10).
Does Gland Pharma Ltd pay a dividend?
Gland Pharma Ltd (GLAND) shows a reported dividend yield of 0.79%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Gland Pharma Ltd in?
Gland Pharma Ltd (GLAND) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is GLAND listed on?
GLAND is listed on NS.
What is Gland Pharma Ltd's net margin?
Gland Pharma Ltd (GLAND) reports a net margin of 25.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.